Gala Pharmaceutical Inc. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e2252f8d-c5d7-407c-9771-f71d625bd842/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-1.9M | 2017-12-01 – 2018-11-30 | evidence 0001683168-19-001047 |
| FY 2017 | $-2.0M | 2016-12-01 – 2017-11-30 | evidence 0001683168-18-000943 |
| FY 2016 | $-170.2k | 2015-12-01 – 2016-11-30 | evidence 0001683168-17-000532 |
| FY 2015 | $-679.5k | 2014-12-01 – 2015-11-30 | evidence 0001517126-16-000300 |
| FY 2014 | $-278.9k | 2013-12-01 – 2014-11-30 | evidence 0001517126-15-000047 |
| FY 2013 | $-121.8k | 2010-03-15 – 2014-05-31 | evidence 0001517126-14-000218 |
| FY 2012 | $-90.7k | 2010-03-15 – 2013-05-31 | evidence 0001517126-13-000171 |
| FY 2011 | $-23.9k | 2010-03-15 – 2012-05-31 | evidence 0001517126-12-000123 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Gala Pharmaceutical Inc. — all facts · Revenue · Operating Income